Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 March 1999

Evaluation of renal and auditory functions in children, in relation to the dosage regimen (once- daily versus multiple-daily) of amikacin

Maria Gołębiowska, Jarosław Wlazłowski, Jarosław Andrzejewski

Med Sci Monit 1999; 5(2): CR280-284 :: ID: 505134

Abstract

The aim of this study was to evaluate side effects of amikacin administration in the treatment of infants and small children, in relation to its dosage. The study group comprised 49 children aged between 2 months and 3 years, who received amikacin due to severe infections - once (21), or twice (three times) a day (28 children). We performed urinalysis as well as serum urea, creatinine and endogenous creatinine clearance levels in each patient before and following treatment completion (Schwartz method). Moreover, we assessed the urine concentration of β2 microglobulin in 30 children (14 from group A and 16 from group B). Hearing was evaluated in 31 patients, including 15 from group A and 16 from group B, by means of subjective testing methods (ABR, SOAE, TOAE). Renal function compromise defined as an increase of serum creatinine by more than 44.2 µl/L compared with primary values was not observed in any of the children. The concentration of β2 microglobulin was significantly higher before treatment and decreased during the course of treatment regardless of amikacin dosage. We noted heavy bilateral hearing impairment in one child. The patient had received aminoglycosides once a day. Due to the coexistence of various risk factors it was impossible to establish whether the hearing impairment was a result of aminoglycoside activity on internal ear cells. In conclusion, the administration of amikacin once a day does not increase the risk of side effects.

Keywords: ototoxicity, nephrotoxicity, dosage, children, amikacin

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750